Dr. Derek Matthew Miletich, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |
Dr. Edwin Gonzalez, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-8229 Fax: 757-953-8225 |
Dr. Adrienne Dawn Pettebone, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1043 |
Dr. Katie Marie Mcauliffe, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-314-0830 |
Dr. William R Shannon, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-3238 |
Dr. Raphael Fajardo Guanzon, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 704 London St # A, Portsmouth, VA 23704 Phone: 757-399-0513 |
Dr. Joel Metzger, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1128 |
Jacob Alan Adams, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |
Joshua Paul, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5269 |
Rani Buglione, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-3647 |
Dr. John Michael Curnes, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |
Dr. Ross Alexander Mullinax, MD, MPH General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |
Dr. Michael James Eliason, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2800 Fax: 757-953-0166 |
Dr. Shannon Renee Blackmer, M. D. General Practice Medicare: Medicare Enrolled Practice Location: Nmrtc, Directorate Of Public Health Services, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757-953-0613 |
Dr. William Kevin Conley Ii, MD, MPH General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1092 |
Dr. Adam Fehringer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1165 |
Dr. Hermann Francisco Gonzalez, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 3145 Sterling Way, Portsmouth, VA 23703 Phone: 757-314-7168 |
Anthony Joseph Marchand, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1787 |
Dr. William Hickman Iv, MD General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |
Dr. Timothy Wayne Barkdoll, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1092 |
News Archive
A protein believed to be limited to the hematopoietic system, called Kindlin-3, has been identified as a major player in both the formation and spread of breast cancer to other organs.
Instructions on boxes and bottles of over-the-counter (OTC) medicines for children in the United States are confusing and hard for parents to understand and follow, according to a study in the December 1 issue of JAMA.
Scientists at the University of Malta and the Institut de Génétique Moléculaire de Montpellier (CNRS/Université de Montpellier) have shown that fruit flies and brewer's yeast can reveal clues about the cause of Spinal Muscular Atrophy (SMA), the most common genetic killer of infants.
Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, today announced the presentation of data evaluating the preclinical safety and efficacy of two of the Company's novel, potent and selective small molecule inhibitors. These inhibitors individually target DOT1L and EZH2, members of a class of epigenic enzymes called histone methyltransferases (HMTs).
› Verified 8 days ago